Evidence map›Paper›PMID 34960120›Full record

ReviewVaccines2021

Human Papilloma Virus Vaccination: Focus on the Italian Situation.

Giovanni Gabutti, Erica d'Anchera, Francesco De Motoli, Marta Savio, Armando Stefanati

Open access · goldAbstract readReview
In one paragraph

Review in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Giovanni GabuttiPro-Tempore National Coordinator of the Work Group "Immunizations and Vaccinal Policies" of the Italian Scientific Society of Hygiene, Preventive Medicine and Public Health (SItI), 16033 Lavagna, Italy.ORCID 0000-0002-7259-4923
Erica d'AncheraPost-Graduate School of Hygiene and Preventive Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-1433-5480
Francesco De MotoliPost-Graduate School of Hygiene and Preventive Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0003-4660-358X
Marta SavioPost-Graduate School of Hygiene and Preventive Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0003-3404-8013
Armando StefanatiDepartment of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.
University of Ferrara · ITItalian Society of Physiotherapy · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papilloma virus (HPV) is a viral agent whose transmission occurs mainly by sexual means. It causes different pathological conditions in both males and females, ranging from benign pathologies up to cancers. The introduction of vaccination has certainly had a major impact in terms of reducing the incidence of both HPV infections and diseases but in the European Union and the European Economic Area (EU/EEA) there are still about more than 13,000 deaths due to cervical cancer each year. To date in Europe and in Italy there are three vaccines available (bi-, tetra-, and nonvalent vaccines). The vaccination campaign started irregularly in Europe and Italy in 2007, with pre-adolescent girls as the primary target. Later, other cohorts were introduced such as 12-year-old boys, additional cohorts of >25-year-old women, women who already underwent cervical surgery and other subjects entitled to free vaccination. The COVID-19 pandemic has strongly impacted on public health services, particularly on vaccinations that, especially during the first pandemic phase, have been often delayed and/or canceled. The most affected vaccinations by the pandemic have been the non-mandatory ones, particularly those addressing the adolescent and adult population, such as immunization against papillomavirus. To date the achievement of the coverage target set by the Italian National Immunization Plan (NIP) has not yet been achieved. The aim of this work is to summarize the current situation in Italy and to discuss the strategies that have been implemented to increase overall vaccination coverage rates.

Indexed as

adolescentscervical cancerCOVID-19HPVHPV vaccinationinfectious diseasespapilloma virusvaccines

Identifiers

PMID34960120
PMCPMC8708418
OpenAlexW3215108488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.